Chronic Renal Diseases, Renal Function Disorder
Conditions
Brief summary
This study aims to conduct a prospective collection of clinical and para-clinical data in patients with Chronic Renal Diseases to identify disease progression factors, markers of renal function, and the pathophysiology of Chronic Renal Diseases complications.
Detailed description
Chronic Renal Diseases have a growing incidence and prevalence in France, with significant consequences in terms of morbidity and mortality, especially cardiovascular, and Public Health. It is necessary to know better: * the mechanisms leading to the progression of the Chronic Renal Diseases * markers to quantify renal function and progression of the Chronic Renal Diseases * the pathophysiology of Chronic Renal Diseases complications, cardiovascular, nutritional, or mineral metabolism in particular. This study aims to conduct a prospective collection of clinical and para-clinical data in patients with Chronic Renal Diseases to identify disease progression factors, markers of renal function, and the pathophysiology of Chronic Renal Diseases complications.
Interventions
PROCEDUREBlood sample
A dry tube of 7 ml of blood, two 4 ml EDTA tubes, a 4 ml heparinized tube and an 8.5 ml ACD-A tube will be collected from the patient.
PROCEDUREUrine sample
The urine will be taken from three 15 ml tubes.
Sponsors
University Hospital, Bordeaux
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Patients with Chronic Renal Disease, stage 2 to 5, non-dialysis patients over the age of 18, * followed in the Nephrology Department of the Bordeaux University Hospital * agreeing to participate in NephroTest * affiliated with social security.
Exclusion criteria
* Patients under 18 years * Patients with acute or rapidly progressive renal failure * Patients with severe comorbidities or comorbidities that are life-threatening in the short term (\<1 year) * Patients who did not give their written consent to be included in the study * Major incapacitated patients and psychiatric patients admitted to hospital
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Estimated Glomerular Filtration Rate measurement | At 1 year after inclusion | by isotope technique |
| Measured Glomerular Filtration Rate | At 1 year after inclusion | by isotope technique |
Outcome results
None listed